Viatris Inc: Drug Recall
Recall #D-0203-2025 · 12/23/2024
Class II: Risk
Recall Details
- Recall Number
- D-0203-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Viatris Inc
- Status
- Terminated
- Date Initiated
- 12/23/2024
- Location
- Canonsburg, PA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,215/30 count bottles
Reason for Recall
Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
Product Description
Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93
Distribution Pattern
USA nationwide.
Other Recalls by Viatris Inc
- Class II: Risk 12/23/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
- Class II: Risk 11/18/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.